Dr. Karen S. Ho is the Senior Director of Translational Medicine at Clene. Dr. Ho is responsible for translating preclinical successes of Clene’s lead drug assets into high medical value with applicability to multiple disease areas. Dr. Ho is also responsible for biomarker development, scientific collaborations, presentations, publications, and grant writing. Prior to Clene, she was the lead scientist at a startup diagnostic testing company, where she streamlined and innovated new methodologies for the scientific interpretation of genetic testing results for children with autism, developmental delays, and/or cognitive impairment. After receiving her BS in Biochemistry summa cum laude from Washington University as a Compton Scholar, Dr. Ho lived in England for two years where she earned a MS in Genetics from the University of Cambridge as a Marshall Scholar. She has a PhD in Developmental Biology from Stanford and completed her postdoctoral training as a National Sleep Foundation Pickwick Scholar and Howard Hughes Medical Institute Postdoctoral Fellow at University of Pennsylvania in the Department of Neuroscience. Dr. Ho serves on several rare disease group Scientific Advisory Boards and holds a concurrent position as adjunct faculty at the University of Utah School of Medicine in the Department of Pediatrics, Division of Medical Genetics.